InForecaster:通过异常检测预测流感血凝素突变
InForecaster: Forecasting Influenza Hemagglutinin Mutations Through the Lens of Anomaly Detection
摘要:
流感病毒血凝素是流感病毒粘附于宿主细胞的重要组成部分。血凝素蛋白是病毒的基因区域之一,具有很高的突变潜力。由于预测突变在生产有效和低成本疫苗中的重要性,试图解决这个问题的解决方案最近获得了极大的关注。突变的历史记录已经被用于在这样的解决方案中训练预测模型。然而,突变和保留的蛋白质之间的不平衡是需要解决的此类模型开发的一个巨大挑战。在这里,我们建议通过异常检测(AD)来应对这一挑战。AD是机器学习(ML)中一个成熟的领域,它试图仅使用正常训练样本来区分看不见的异常和正常模式。通过将突变视为异常行为,我们可以受益于最近出现的该领域的现有丰富解决方案。这样的方法也适合未突变与突变训练样本数量之间极端不平衡的问题设置。受此启发,我们的方法试图找到一个紧凑的表示未变异的样本,同时迫使异常从正常的。这有助于模型尽可能多地学习正常训练样本之间的共享唯一表示,从而提高测试时突变样本与未突变样本的可识别性和可检测性。我们在四个公开的数据集上进行了大量的实验,包括3个不同的血凝素蛋白数据集和一个SARS-CoV-2数据集,并通过不同的标准标准证明了我们的方法的有效性。
英文摘要:
The influenza virus hemagglutinin is an important part of the virus attachment to the host cells. The hemagglutinin proteins are one of the genetic regions of the virus with a high potential for mutations. Due to the importance of predicting mutations in producing effective and low-cost vaccines, solutions that attempt to approach this problem have recently gained a significant attention. A historical record of mutations have been used to train predictive models in such solutions. However, the imbalance between mutations and the preserved proteins is a big challenge for the development of such models that needs to be addressed. Here, we propose to tackle this challenge through anomaly detection (AD). AD is a well-established field in Machine Learning (ML) that tries to distinguish unseen anomalies from the normal patterns using only normal training samples. By considering mutations as the anomalous behavior, we could benefit existing rich solutions in this field that have emerged recently. Such methods also fit the problem setup of extreme imbalance between the number of unmutated vs. mutated training samples. Motivated by this formulation, our method tries to find a compact representation for unmutated samples while forcing anomalies to be separated from the normal ones. This helps the model to learn a shared unique representation between normal training samples as much as possible, which improves the discernibility and detectability of mutated samples from the unmutated ones at the test time. We conduct a large number of experiments on four publicly available datasets, consisting of 3 different hemagglutinin protein datasets, and one SARS-CoV-2 dataset, and show the effectiveness of our method through different standard criteria.
机构、总结、中文摘要均由AI分析而来,可能存在错误,请以论文正文为准。